Institut Català d'Oncologia
🇪🇸Spain
Clinical Trials
38
Active:5
Completed:13
Trial Phases
5 Phases
Early Phase 1:1
Phase 1:7
Phase 2:6
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (31 trials with phase data)• Click on a phase to view related trials
Not Applicable
15 (48.4%)Phase 1
7 (22.6%)Phase 2
6 (19.4%)Phase 3
2 (6.5%)Early Phase 1
1 (3.2%)Implementing an Adapted Smoke-free Homes Intervention in Spain
Not Applicable
Recruiting
- Conditions
- Secondhand Tobacco Smoke Exposure ReductionSmoking Prevention
- First Posted Date
- 2025-04-17
- Last Posted Date
- 2025-06-04
- Lead Sponsor
- Institut Català d'Oncologia
- Target Recruit Count
- 408
- Registration Number
- NCT06932276
- Locations
- 🇪🇸
Catalan Institute of Oncology, Barcelona, Catalonia, Spain
Early Versus Standard Care in Cancer Patients in Phase 1 Clinical Trials
Not Applicable
Completed
- Conditions
- Emotional Adjustment
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Institut Català d'Oncologia
- Target Recruit Count
- 186
- Registration Number
- NCT06646315
- Locations
- 🇪🇸
Institut Català d'Oncologia, L'Hospitalet De Llobregat, Barcelona, Spain
eHealth Interventions for Breast Cancer Cognitive Impairment
Not Applicable
Not yet recruiting
- Conditions
- Breast CancerCognitive Dysfunction
- First Posted Date
- 2023-10-26
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Institut Català d'Oncologia
- Target Recruit Count
- 176
- Registration Number
- NCT06103318
Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer
Recruiting
- Conditions
- HER2-positive Breast CancerBreast CancerNeoplasms
- Interventions
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Institut Català d'Oncologia
- Target Recruit Count
- 80
- Registration Number
- NCT05912062
- Locations
- 🇪🇸
Institut Català d'Oncologia l'Hospitalet, Hospitalet de Llobregat, Barcelona, Spain
Breast Cancer With Intraoperative Radiotherapy Followed by Hypofractionated External Beam Radiotherapy
Phase 2
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2022-08-12
- Last Posted Date
- 2022-08-15
- Lead Sponsor
- Institut Català d'Oncologia
- Target Recruit Count
- 89
- Registration Number
- NCT05498311
- Locations
- 🇪🇸
Evelyn Martínez, Hospitalet de Llobregat, Barcelona, Spain
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
News
Bladder-Preserving Treatment Shows Promise: Radiation Plus Dual Immunotherapy Achieves 93% Complete Response in MIBC
A novel combination of radiation therapy with durvalumab and tremelimumab immunotherapy achieved a 93% complete response rate in muscle-invasive bladder cancer patients, offering a promising bladder-preserving alternative.